Tofacitinib Tablet, Film Coated, Extended Release
Product Images NDC 60505-4858

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 60505-4858). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Btl11mg.jpg (Btl11mg)

This text provides information about Tofacitinib 11 mg tablets containing an equivalent of 17.77 mg Tofacitinib Citrate. It also includes storage instructions, dosage details, and the manufacturer's information. The tablets are extended-release and come in a pack of 30. Additionally, it mentions that the tablets should not be repackaged, and pharmacists should dispense them with a Medication Guide. Further details can be found in the accompanying Prescribing Information.*

FDA Label Image

Figure1.jpg (Figure1)

This appears to be a list describing intrinsic factors related to weight, age, gender, ethnicity, renal impairment, and hepatic impairment. The text mentions different categories such as mild, moderate, and severe for renal and hepatic impairment, and provides a ratio and 90% confidence interval. Overall, this text may be used for evaluating the impact of these intrinsic factors on a particular situation or study.*

FDA Label Image

Figure2.jpg (Figure2)

This text appears to show information related to the coadministration of various drugs and their effects on the pharmacokinetics (PK) of Methotrexate, Midazolam, Oral Contraceptives (Levonorgestrel and Ethinyl Estradiol), and Metformin. The text includes parameters such as AUC (area under the curve) and Cmax (maximum plasma concentration), along with ratios and confidence intervals (CI). This data can be used to evaluate potential drug interactions and their impact on the metabolism and levels of the mentioned drugs.*

FDA Label Image

Figure3.jpg (Figure3)

Not available.*

FDA Label Image

Figure4.jpg (Figure4)

FDA Label Image

Figure5.jpg (Figure5)

FDA Label Image

Figure6.jpg (Figure6)

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.